Company intelligence / Profile preview

Inocras

San Diego, California, United Statesinocras.com ↗

Ownership: Private
Development stage: Commercial

Overview

Inocras has developed a proprietary, AI-driven whole genome sequencing platform with CAP/CLIA certification. Its main products—CancerVision, MRDVision, and RareVision—offer comprehensive genomic insights for cancer diagnosis/treatment monitoring and rare disease diagnosis. Clinical data highlight high sensitivity (>99% for certain variants) and rapid turnaround times (~2 weeks). MRDVision demonstrates industry-leading sensitivity in minimal residual disease detection compared to leading NGS assays.

Therapeutic areas: OncologyRare Diseases
Modalities: Diagnostic testGenomic sequencing
Industry: Molecular Diagnostics

Drug pipeline

3 assets

CancerVision

Commercial

Indications: Cancer

2 more assets in the full pipeline.

Request access →

Partnerships

Massive Bio (clinical trial matching/cancer care alliance)Fore Genomics (pediatric/newborn screening partnership)Center for Data Driven Discovery in Biomedicine (collaborative research on sinonasal cancer)

Beyond the preview

Go deeper on Inocras.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inocras.

Explore the full profile